Dr. Robert David Herscowitz, MD

Dr. Herscowitz practices at Pulmonary Associates Ltd in Alexandria, Virginia.

Dr. Herscowitz's NPI, 1801838776, was assigned on June 12, 2006. Dr. Herscowitz graduated from Georgetown University School Of Medicine in 1990. Dr. Herscowitz holds Virginia license 0101055633.

Dr. Herscowitz's primary practice is Pulmonary Associates Ltd, at 5216 Dawes Ave, Alexandria, VA 22311 in Alexandria City. The practice phone is (703) 931-4746.

Dr. Herscowitz's primary practice is Pulmonary Associates Ltd in Alexandria, Virginia. Dr. Herscowitz is also affiliated with Inova Alexandria Hospital. The medical group on file is Pulmonary Associates. Dmand AI also links Dr. Herscowitz to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Herscowitz practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Herscowitz's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Herscowitz is board certified in pulmonary disease by the American Board of Internal Medicine. Dmand AI has Dr. Herscowitz's licenses on file in 3 states: Virginia, District of Columbia and Pennsylvania.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, pleural effusion, pneumonia, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Herscowitz treats.

CMS data shows 3,039 Medicare services from Dr. Herscowitz across 10 procedure codes in 2024, for 693 Medicare patients. Medicare paid $231,105 for them. Every service was in an office.

CMS counts 693 Medicare patients who saw Dr. Herscowitz in 2024. The largest group is 75 to 84, with 327 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Herscowitz's median patient age at 73, with 54% women.

In 2024, Dr. Herscowitz wrote 2,142 Medicare Part D claims for 358 patients. CMS names the drug for 2,055 of them, across 34 drugs with 11 or more claims each, at $1,108,045 in total drug cost. In 2023, CMS named 1,522 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Herscowitz for performance year 2024, reported individually. Dr. Herscowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Herscowitz as offering telehealth.

CMS Open Payments shows 298 general payments to Dr. Herscowitz from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $1,203.

Dmand AI lists 2 awards for Dr. Herscowitz, most recently CMS Stage 1 EHR in 2013.

Dr. Herscowitz graduated from Georgetown University School Of Medicine in 1990.

Dr. Herscowitz is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.